Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Frieman

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Virology|October 17, 2023
Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2Robert M Johnson, Jeremy Ardanuy, Holly Hammond, et al.
Plos One|March 23, 2018
MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cellsYu Cong, Brit J Hart, Robin Gross, et al.
Mbio|December 22, 2021
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging VirusesJudith M White, Joshua T Schiffer, Rachel A Bender Ignacio, et al.
Journal of Virology|May 8, 2009
Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infectionBarry Rockx, Tracey Baas, Gregory A Zornetzer, et al.
The Journal of Infectious Diseases|January 28, 2021
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome CoronavirusSumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, et al.
Frontiers in Immunology|October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2Yun Ji, Qi Zhang, Lin Cheng, et al.
Mbio|June 19, 2014
Standards for sequencing viral genomes in the era of high-throughput sequencingJason T Ladner, Brett Beitzel, Patrick S G Chain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2022
Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 VariantsJianyu Lai, Kristen K Coleman, S H Sheldon Tai, et al.
Biorxiv : the Preprint Server for Biology|November 30, 2021
Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patientsMegan M Sperry, Tomiko Oskotsky, Ivana MariÄ, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Virology|October 17, 2023
Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2Robert M Johnson, Jeremy Ardanuy, Holly Hammond, et al.
Plos One|March 23, 2018
MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cellsYu Cong, Brit J Hart, Robin Gross, et al.
Mbio|December 22, 2021
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging VirusesJudith M White, Joshua T Schiffer, Rachel A Bender Ignacio, et al.
Journal of Virology|May 8, 2009
Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infectionBarry Rockx, Tracey Baas, Gregory A Zornetzer, et al.
The Journal of Infectious Diseases|January 28, 2021
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome CoronavirusSumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, et al.
Frontiers in Immunology|October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2Yun Ji, Qi Zhang, Lin Cheng, et al.
Mbio|June 19, 2014
Standards for sequencing viral genomes in the era of high-throughput sequencingJason T Ladner, Brett Beitzel, Patrick S G Chain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2022
Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 VariantsJianyu Lai, Kristen K Coleman, S H Sheldon Tai, et al.
Biorxiv : the Preprint Server for Biology|November 30, 2021
Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patientsMegan M Sperry, Tomiko Oskotsky, Ivana MariÄ, et al.
Pageof 6